当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Molecular Medicine杂志
Molecular Medicine
基本信息
期刊名称 Molecular Medicine
MOL MED
期刊ISSN 1076-1551
期刊官方网站 https://molmed.biomedcentral.com
是否OA Yes
出版商 BioMed Central Ltd
出版周期 Bimonthly
文章处理费 登录后查看
始发年份 1994
年文章数 164
影响因子 6.0(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学3区
CELL BIOLOGY 细胞生物学4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 8.6 1.446 0.907
Medicine
Genetics (clinical)
15/99 85%
Biochemistry, Genetics and Molecular Biology
Genetics
63/347 81%
Biochemistry, Genetics and Molecular Biology
Molecular Biology
103/410 75%
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
47/178 73%
补充信息
自引率 1.7%
H-index 110
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1076-1551%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/mome
收稿范围
Molecular Medicine is an open access journal publishing recent findings that elucidate disease pathogenesis at the molecular or physiological level, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. Manuscripts containing material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes are considered for publication. Manuscripts submitted to Molecular Medicine should describe the implications of the results for human disease and medicine, at a level approachable by our broad audience.

Criteria to consider for studies involving lnc-RNAs or micro-RNAs:

·        As lncRNAs and miRNAs have multiple targets, claims of their function mediated by a single target or pathway will not be accepted, unless multiple additional targets are investigated to support functional specificity.

·        The rationale to investigate a specific lncRNA or miRNA needs to be specified upfront in the introduction and justified in the context of other miRNAs known to be functional in that specific field.

·        The proposed function of the lnc-RNA or miRNA should be validated by gain and loss of function studies.

·        Primary cells should be used whenever possible to confirm findings in cell lines.

·        In depth investigation in the signaling pathway(s) regulated by the RNA species should be conducted.

·        Insight into the regulation of the RNA species and how it relates to the pathologic state should be provided.

·        If applicable: Details of initial screen used to identify RNA species involvement in pathway/disease (number of subjects, statistical tests employed, percent change from controls).
收录体裁
投稿指南 https://molmed.biomedcentral.com/submission-guidelines
投稿模板
参考文献格式
编辑信息

Editor-in-Chief
Betty Diamond, The Feinstein Institutes for Medical Research, USA

Executive Editor
Valentin A Pavlov, The Feinstein Institutes for Medical Research, USA

Managing Editor
Maria Ruggieri, The Feinstein Institutes for Medical Research, USA

Coordinating Editor
Sonya Vanpatten, The Feinstein Institutes for Medical Research, USA

Contributing Editors
Frederick W Alt, Howard Hughes Medical Institute, USA
Marco E Bianchi, San Raffaele Scientific Institute, Italy
Timothy Billiar, University of Pittsburgh, USA
Uli Broedl, Boehringer Ingelheim, Canada
Michael Bukrinsky, George Washington University, USA 
Patrice D Cani, UCLouvain, University of Louvain, Belgium
Anthony Cerami, Araim Pharmaceuticals, USA
Nicholas Chiorazzi, The Feinstein Institutes for Medical Research, USA 
José C Crispín Acuña, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico
Robert J Desnick, Mount Sinai School of Medicine, USA 
Charles A Dinarello, University of Colorado Health Sciences, USA 
Hannelore Ehrenreich, Max-Planck Institute for Experimental Medicine, Germany
Laurie Glimcher, Weill Cornell Medicine, USA
Paul Greengard, Rockefeller University, USA 
Peter K Gregersen, The Feinstein Institutes for Medical Research, USA 
Alexis M Kalergis, Pontificia Universidad Católica de Chile, Chile
Lars Klareskog, Karolinska Institute, Sweden
Mike McCune, University of California at San Francisco, USA
Carl F Nathan, Weill Cornell Medicine, USA
Haitao Niu, Peking Union Medical College, China
Bert W O'Malley, Baylor College of Medicine, USA
Athanasios G Papavassiliou, University of Athens, Greece
Marc H Symons, The Feinstein Institutes for Medical Research, USA
Csaba Szabo, University of Fribourg, Switzerland
Christoph Thiemermann, Queen Mary University London, UK
Kevin J Tracey, The Feinstein Institute for Medical Research, USA
H Shaw Warren, Massachusetts General Hospital, USA

Associate Editors
Dimitar B Avtanski, The Feinstein Institutes for Medical Research, USA
Lior Brimberg, The Feinstein Institutes for Medical Research, USA
Max Brenner, The Feinstein Institutes for Medical Research, USA
Eric H Chang, The Feinstein Institutes for Medical Research, USA
Salvatore Coniglio, Kean University, USA
Harshil Dhruv, The Translational Genomics Research Institute, USA
Maya Frankfurt, Hofstra North Shore-LIJ School of Medicine, USA
Paolo Guarnieri, Boehringer Ingelheim, USA
Jared Huston, The Feinstein Institutes for Medical Research, USA
Sun Jung Kim, The Feinstein Institutes for Medical Research, USA
Ben Lu, Central South University, China
Susan Malkiel, The Feinstein Institutes for Medical Research, USA
Philippe Marambaud, The Feinstein Institutes for Medical Research, USA
Kaie Ojamaa, New York Institute of Technology, USA
Susanna Park, University of California Davis, USA
Shresh Pathak, The Feinstein Institutes for Medical Research, USA
Ameya P Patil, Medical College of Wisconsin, USA
Doru Paul, Weill Cornell Medicine, USA
Elisabeth Ploran, Hofstra North Shore-LIJ School of Medicine, USA
Viswanathan Rajagopalan, New York Institute of Technology, USA
Bodour Salhia, University of Southern California, USA
Frances Santiago-Schwarz, The Feinstein Institutes for Medical Research, USA
Olga Savinova, New York Institute of Technology, USA
Amnon Schlegel, University of Utah, USA
Kim R Simpfendorfer, The Feinstein Institutes for Medical Research, USA
Myoungsun Son, The Feinstein Institutes for Medical Research, USA
Joel Stern, Hofstra North Shore-LIJ School of Medicine, USA
Xingmin Sun, University of South Florida, USA
Nhan Tran, Mayo Clinic, USA
Weng-Lang Yang, The Feinstein Institutes for Medical Research, USA
Sophia Yancopoulos, The Feinstein Institutes for Medical Research, USA
Xinhua Zhu, The Feinstein Institutes for Medical Research, USA


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug